Search results
UPDATE 5-Shah Capital urges Novavax shareholders to vote against three directors
Reuters via Yahoo Finance· 2 hours agoHedge fund Shah Capital on Monday urged Novavax shareholders to vote against the re-election of three directors and opposed proposals related to executive ...
Novavax's top shareholder Shah Capital ramps up efforts for board shakeup
AOL· 7 hours agoShah Capital, which currently owns a near 7.5% stake in Novavax and is its third-largest shareholder, reiterated that the company was "undervalued
Novavax, Inc. (NASDAQ:NVAX) Shares Sold by Federated Hermes Inc.
ETF DAILY NEWS· 15 hours agoFederated Hermes Inc. lowered its position in shares of Novavax, Inc. (NASDAQ:NVAX – Free Report) by 88.6% in the fourth quarter, according to the company in its most recent ...
What to know about the new 'FLiRT' COVID variants that are spreading: Your guide to the latest virus...
Yahoo Life· 4 hours agoHere’s your go-to guide with everything you need to know about COVID-19, including the latest...
Novavax (NVAX) Increases Despite Market Slip: Here's What You Need to Know
Zacks· 7 days agoFree Report) closed at $4.33, marking a +0.93% move from the previous day. Shares of the vaccine maker have depreciated by 7.74% over the course of the past month, underperforming ...
3 Beaten-Down Stocks I Wouldn't Touch With a 10-Foot Pole
Motley Fool via Yahoo Finance· 1 week agoWith that said, let's consider three beaten-down stocks that don't look like bargains at all: ...
The path to a better tuberculosis vaccine runs through Montana
Bozeman Daily Chronicle· 1 week agoThe BCG (Bacille Calmette-Guérin) vaccine, created in 1921, remains the sole TB vaccine. One effort...
COVID Vaccine Study Finds Small Signal of Seizure Risk in Young Kids
MedPage Today· 2 weeks ago-BioNTech BNT162b2 (Comirnaty) vaccine, Patricia Lloyd, PhD, ScM, of the FDA in Silver Spring,...
ESCMID 2024: Cutting-edge vaccines in development for a healthier tomorrow
Clinical Trials Arena via Yahoo Finance· 5 days agoThe R21/Matrix-M vaccine, developed by Oxford University and the Serum Institute of India,...
Is Moderna Stock A Buy On Its Eye-Popping First-Quarter Sales Beat?
Investor's Business Daily· 4 days agoThe company noted that it achieved 48% market share for Covid vaccines in the U.S. during the fall...